De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Stericycle Toekomstige groei

Future criteriumcontroles 3/6

Stericycle zal naar verwachting groeien in winst en omzet met respectievelijk 38.9% en 4.2% per jaar. De winst per aandeel zal naar verwachting groeien met 39.7% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.5% zijn.

Belangrijke informatie

38.9%

Groei van de winst

39.7%

Groei van de winst per aandeel

Commercial Services winstgroei	14.7%
Inkomstengroei	4.2%
Toekomstig rendement op eigen vermogen	11.5%
Dekking van analisten	Good
Laatst bijgewerkt	06 Sep 2024

Recente toekomstige groei-updates

Recent updates

Stericycle (NASDAQ:SRCL) Has A Somewhat Strained Balance Sheet

Sep 03

Waste Management's Big Move Is A Win For Stericycle

Jun 04

Stericycle's (NASDAQ:SRCL) Returns On Capital Not Reflecting Well On The Business

May 29

Stericycle: Watch Potential Revenue Recovery And Margin Improvement

May 22

Stericycle, Inc.'s (NASDAQ:SRCL) Business Is Yet to Catch Up With Its Share Price

May 08

We Think Stericycle (NASDAQ:SRCL) Can Stay On Top Of Its Debt

Apr 02

Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 47% Undervaluation?

Mar 07

Stericycle: Earnings Beat And Above-Expectations Guidance Reinforce My Buy Rating

Mar 03

Stericycle, Inc. (NASDAQ:SRCL) Shares Could Be 44% Below Their Intrinsic Value Estimate

Dec 01

Stericycle (NASDAQ:SRCL) Hasn't Managed To Accelerate Its Returns

Oct 26

Here's Why Stericycle (NASDAQ:SRCL) Can Manage Its Debt Responsibly

Sep 13

Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 37% Undervaluation?

Jul 19

Stericycle (NASDAQ:SRCL) Will Be Hoping To Turn Its Returns On Capital Around

Jul 03

Stericycle (NASDAQ:SRCL) Seems To Use Debt Quite Sensibly

Jun 15

At US$42.07, Is Stericycle, Inc. (NASDAQ:SRCL) Worth Looking At Closely?

Apr 24

An Intrinsic Calculation For Stericycle, Inc. (NASDAQ:SRCL) Suggests It's 40% Undervalued

Apr 04

These Return Metrics Don't Make Stericycle (NASDAQ:SRCL) Look Too Strong

Mar 14

We Think Stericycle (NASDAQ:SRCL) Is Taking Some Risk With Its Debt

Feb 24

What Is Stericycle, Inc.'s (NASDAQ:SRCL) Share Price Doing?

Jan 16

An Intrinsic Calculation For Stericycle, Inc. (NASDAQ:SRCL) Suggests It's 37% Undervalued

Dec 23

These Return Metrics Don't Make Stericycle (NASDAQ:SRCL) Look Too Strong

Dec 02

Stericycle's (NASDAQ:SRCL) Conservative Accounting Might Explain Soft Earnings

Nov 10

We Think Stericycle (NASDAQ:SRCL) Is Taking Some Risk With Its Debt

Oct 11

Stericycle: Muted Outlook, Fair Valuations

Aug 30

Stericycle Q2 2022 Earnings Preview

Aug 04

Be Wary Of Stericycle (NASDAQ:SRCL) And Its Returns On Capital

Aug 02

Is Stericycle (NASDAQ:SRCL) A Risky Investment?

Jun 28

Stericycle: The Risks Outweigh The Reward

Jun 03

Capital Allocation Trends At Stericycle (NASDAQ:SRCL) Aren't Ideal

Apr 25

Is Stericycle, Inc. (NASDAQ:SRCL) Trading At A 40% Discount?

Mar 29

Stericycle: A Neutral View

Oct 22

Stericycle: A Successful Turnaround Is Likely

Aug 08

Stericycle Q1 2021 Earnings Preview

Apr 28

Stericycle: Future Profitability Influenced By Divestments And ERP Implementation

Feb 04

Winst- en omzetgroeiprognoses

NasdaqGS:SRCL - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	2,939	306	328	471	3
12/31/2025	2,793	178	257	406	8
12/31/2024	2,695	99	195	345	8
6/30/2024	2,632	36	-69	78	N/A
3/31/2024	2,640	-19	1	139	N/A
12/31/2023	2,659	-21	112	243	N/A
9/30/2023	2,678	-4	222	350	N/A
6/30/2023	2,715	22	248	374	N/A
3/31/2023	2,725	81	157	289	N/A
12/31/2022	2,705	56	68	200	N/A
9/30/2022	2,692	7	7	144	N/A
6/30/2022	2,650	-87	8	135	N/A
3/31/2022	2,643	-68	72	202	N/A
12/31/2021	2,647	-28	186	303	N/A
9/30/2021	2,646	38	257	367	N/A
6/30/2021	2,633	23	368	473	N/A
3/31/2021	2,559	-11	406	511	N/A
12/31/2020	2,676	-57	411	530	N/A
9/30/2020	2,820	-325	284	412	N/A
6/30/2020	3,016	-303	224	384	N/A
3/31/2020	3,264	-329	126	294	N/A
12/31/2019	3,309	-347	54	248	N/A
9/30/2019	3,362	-446	82	277	N/A
6/30/2019	3,384	-369	-169	6	N/A
3/31/2019	3,421	-312	-77	92	N/A
12/31/2018	3,486	-253	35	166	N/A
9/30/2018	3,521	148	58	207	N/A
6/30/2018	3,549	166	357	501	N/A
3/31/2018	3,583	-9	N/A	451	N/A
12/31/2017	3,581	23	N/A	509	N/A
9/30/2017	3,599	-47	N/A	535	N/A
6/30/2017	3,607	-21	N/A	554	N/A
3/31/2017	3,581	165	N/A	572	N/A
12/31/2016	3,562	178	N/A	561	N/A
9/30/2016	3,544	236	N/A	515	N/A
6/30/2016	3,373	244	N/A	457	N/A
3/31/2016	3,197	295	N/A	415	N/A
12/31/2015	2,986	257	N/A	386	N/A
9/30/2015	2,775	269	N/A	397	N/A
6/30/2015	2,724	282	N/A	389	N/A
3/31/2015	2,649	276	N/A	435	N/A
12/31/2014	2,556	326	N/A	449	N/A
9/30/2014	2,447	322	N/A	414	N/A
6/30/2014	2,313	320	N/A	467	N/A
3/31/2014	2,199	316	N/A	453	N/A
12/31/2013	2,143	311	N/A	405	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei SRCL ( 38.9% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van SRCL ( 38.9% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.2% per jaar).

Hoge groeiwinsten: De winst van SRCL zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van SRCL ( 4.2% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.7% per jaar).

Hoge groei-inkomsten: De omzet van SRCL ( 4.2% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen SRCL zal naar verwachting over 3 jaar laag zijn ( 11.5 %).

Stericycle Toekomstige groei

Future criteriumcontroles 3/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 15% to US$61.83

Consensus EPS estimates fall by 10%

Consensus EPS estimates fall by 49%

Consensus EPS estimates fall by 40%

Price target decreased by 8.5% to US$62.00

Price target decreased to US$65.20

Recent updates

Stericycle (NASDAQ:SRCL) Has A Somewhat Strained Balance Sheet

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Waste Management, Inc. (NYSE:WM) entered into an Agreement and Plan of Merger to acquire Stericycle, Inc. (NasdaqGS:SRCL) for $5.8 billion.

Waste Management's Big Move Is A Win For Stericycle

Stericycle's (NASDAQ:SRCL) Returns On Capital Not Reflecting Well On The Business

Stericycle: Watch Potential Revenue Recovery And Margin Improvement

Stericycle, Inc.'s (NASDAQ:SRCL) Business Is Yet to Catch Up With Its Share Price

First quarter 2024 earnings: EPS and revenues miss analyst expectations

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Stericycle, Inc., Annual General Meeting, May 21, 2024

We Think Stericycle (NASDAQ:SRCL) Can Stay On Top Of Its Debt

President exercised options and sold US$615k worth of stock

President exercised options and sold US$808k worth of stock

Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 47% Undervaluation?

Stericycle: Earnings Beat And Above-Expectations Guidance Reinforce My Buy Rating

Price target increased by 15% to US$61.83

Returns On Capital At Stericycle (NASDAQ:SRCL) Paint A Concerning Picture

Stericycle, Inc.'s (NASDAQ:SRCL) Shares May Have Run Too Fast Too Soon

We Think Stericycle (NASDAQ:SRCL) Can Stay On Top Of Its Debt

Stericycle, Inc. (NASDAQ:SRCL) Shares Could Be 44% Below Their Intrinsic Value Estimate

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Stericycle (NASDAQ:SRCL) Hasn't Managed To Accelerate Its Returns

Consensus EPS estimates fall by 10%

Here's Why Stericycle (NASDAQ:SRCL) Can Manage Its Debt Responsibly

Stericycle, Inc. Reports Impairment Changes for the Second Quarter Ended June 30, 2023

Consensus EPS estimates fall by 49%

Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 37% Undervaluation?

Stericycle (NASDAQ:SRCL) Will Be Hoping To Turn Its Returns On Capital Around

Stericycle (NASDAQ:SRCL) Seems To Use Debt Quite Sensibly

Executive VP & Chief People Officer recently bought US$309k worth of stock

Enviri Corporation Reaches an Amicable Agreement with Stericycle, Inc

Stericycle, Inc. Approves the Election of Victoria L. Dolan as Director

Consensus EPS estimates fall by 40%

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

At US$42.07, Is Stericycle, Inc. (NASDAQ:SRCL) Worth Looking At Closely?

Executive VP exercised options and sold US$109k worth of stock

An Intrinsic Calculation For Stericycle, Inc. (NASDAQ:SRCL) Suggests It's 40% Undervalued

These Return Metrics Don't Make Stericycle (NASDAQ:SRCL) Look Too Strong

President exercised options and sold US$189k worth of stock

Director recently bought US$287k worth of stock

Price target decreased by 8.5% to US$62.00

We Think Stericycle (NASDAQ:SRCL) Is Taking Some Risk With Its Debt

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued

What Is Stericycle, Inc.'s (NASDAQ:SRCL) Share Price Doing?

An Intrinsic Calculation For Stericycle, Inc. (NASDAQ:SRCL) Suggests It's 37% Undervalued

Stericycle, Inc. Appoints Naren K. Gursahaney to the Board of Directors, Effective January 1, 2023

Infomedia Group, Inc. acquired Stericycle Communication Solutions, Inc. from Stericycle, Inc. (NasdaqGS:SRCL) for $45 million.

These Return Metrics Don't Make Stericycle (NASDAQ:SRCL) Look Too Strong

Insufficient new directors

Stericycle's (NASDAQ:SRCL) Conservative Accounting Might Explain Soft Earnings

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

We Think Stericycle (NASDAQ:SRCL) Is Taking Some Risk With Its Debt

Stericycle: Muted Outlook, Fair Valuations

Price target decreased to US$65.20

Stericycle Q2 2022 Earnings Preview

Be Wary Of Stericycle (NASDAQ:SRCL) And Its Returns On Capital

Executive VP exercised options and sold US$93k worth of stock

Is Stericycle (NASDAQ:SRCL) A Risky Investment?

Stericycle: The Risks Outweigh The Reward

Insufficient new directors

Price target decreased to US$63.67

President exercised options and sold US$62k worth of stock

First quarter 2022 earnings: EPS misses analyst expectations

Capital Allocation Trends At Stericycle (NASDAQ:SRCL) Aren't Ideal

Stericycle, Inc., Annual General Meeting, May 26, 2022

Stericycle, Inc. Announces New Safeshield™ Medical Waste Containers

High number of new directors

Is Stericycle, Inc. (NASDAQ:SRCL) Trading At A 40% Discount?